Mining novel natural reactive oxygen species (ROS) inhibitors by targeting Rho Kinase for prevention of secondary spinal cord injury: An in-silico trial using traditional Chinese m...

by Lei Fang, Ziliang Shen, Shengming Xu, Yu Chen, Shuqiang Wang
Published 2020-07-01

NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC

by Wenjie Tao, Guocai Tian, Shengming Xu, Jiayi Li, Zhiyuan Zhang, Jiang Li
Published 2021-08-01

HIV-1 diversity and drug-resistant mutations in infected individuals in Changchun, China.

by Ming Yan, Ke Zhao, Juan Du, Linzhang Li, Donglin Wu, Shengming Xu, Xiangchao Zeng, Guanjun Wang, Xiao-Fang Yu
Published 2014-01-01